221 related articles for article (PubMed ID: 10941932)
1. Differential level in co-down-modulation of CD4 and CXCR4 primed by HIV-1 gp120 in response to phorbol ester, PMA, among HIV-1 isolates.
Tahara-Hanaoka S; Ushijima Y; Tarui H; Wada M; Hara T; Imanishi S; Yamaguchi T; Hattori T; Nakauchi H; Koito A
Microbiol Immunol; 2000; 44(6):489-98. PubMed ID: 10941932
[TBL] [Abstract][Full Text] [Related]
2. Phorbol ester-induced down modulation of tailless CD4 receptors requires prior binding of gp120 and suggests a role for accessory molecules.
Golding H; Dimitrov DS; Manischewitz J; Broder CC; Robinson J; Fabian S; Littman DR; Lapham CK
J Virol; 1995 Oct; 69(10):6140-8. PubMed ID: 7545243
[TBL] [Abstract][Full Text] [Related]
3. Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4.
Cho MW; Lee MK; Carney MC; Berson JF; Doms RW; Martin MA
J Virol; 1998 Mar; 72(3):2509-15. PubMed ID: 9499115
[TBL] [Abstract][Full Text] [Related]
4. CD4-Chemokine receptor hybrids in human immunodeficiency virus type 1 infection.
Klasse PJ; Rosenkilde MM; Signoret N; Pelchen-Matthews A; Schwartz TW; Marsh M
J Virol; 1999 Sep; 73(9):7453-66. PubMed ID: 10438835
[TBL] [Abstract][Full Text] [Related]
5. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.
Catani MV; Corasaniti MT; Navarra M; Nisticò G; Finazzi-Agrò A; Melino G
J Neurochem; 2000 Jun; 74(6):2373-9. PubMed ID: 10820198
[TBL] [Abstract][Full Text] [Related]
6. Dissociation of the CD4 and CXCR4 binding properties of human immunodeficiency virus type 1 gp120 by deletion of the first putative alpha-helical conserved structure.
Missé D; Cerutti M; Schmidt I; Jansen A; Devauchelle G; Jansen F; Veas F
J Virol; 1998 Sep; 72(9):7280-8. PubMed ID: 9696823
[TBL] [Abstract][Full Text] [Related]
7. Chemokine receptor-usage of clinical HIV-1 isolates obtained from patients with HIV-1 infection in late clinical stages using PHA-blast.
Matsuda S; Miyata M
Microbiol Immunol; 1999; 43(10):967-74. PubMed ID: 10585143
[TBL] [Abstract][Full Text] [Related]
8. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
Lee S; Lapham CK; Chen H; King L; Manischewitz J; Romantseva T; Mostowski H; Stantchev TS; Broder CC; Golding H
J Virol; 2000 Jun; 74(11):5016-23. PubMed ID: 10799575
[TBL] [Abstract][Full Text] [Related]
9. Identification of gp120 binding sites on CXCR4 by using CD4-independent human immunodeficiency virus type 2 Env proteins.
Lin G; Baribaud F; Romano J; Doms RW; Hoxie JA
J Virol; 2003 Jan; 77(2):931-42. PubMed ID: 12502809
[TBL] [Abstract][Full Text] [Related]
10. Retroviral vector targeting to human immunodeficiency virus type 1-infected cells by receptor pseudotyping.
Somia NV; Miyoshi H; Schmitt MJ; Verma IM
J Virol; 2000 May; 74(9):4420-4. PubMed ID: 10756057
[TBL] [Abstract][Full Text] [Related]
11. Promonocytic U937 subclones expressing CD4 and CXCR4 are resistant to infection with and cell-to-cell fusion by T-cell-tropic human immunodeficiency virus type 1.
Moriuchi H; Moriuchi M; Arthos J; Hoxie J; Fauci AS
J Virol; 1997 Dec; 71(12):9664-71. PubMed ID: 9371631
[TBL] [Abstract][Full Text] [Related]
12. Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events.
Doranz BJ; Baik SS; Doms RW
J Virol; 1999 Dec; 73(12):10346-58. PubMed ID: 10559353
[TBL] [Abstract][Full Text] [Related]
13. Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity.
LaBranche CC; Hoffman TL; Romano J; Haggarty BS; Edwards TG; Matthews TJ; Doms RW; Hoxie JA
J Virol; 1999 Dec; 73(12):10310-9. PubMed ID: 10559349
[TBL] [Abstract][Full Text] [Related]
14. Roles of CD4 and coreceptors in binding, endocytosis, and proteolysis of gp120 envelope glycoproteins derived from human immunodeficiency virus type 1.
Kozak SL; Kuhmann SE; Platt EJ; Kabat D
J Biol Chem; 1999 Aug; 274(33):23499-507. PubMed ID: 10438529
[TBL] [Abstract][Full Text] [Related]
15. T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1alpha contains mutations in the envelope gp120 but does not show a switch in coreceptor use.
Schols D; Esté JA; Cabrera C; De Clercq E
J Virol; 1998 May; 72(5):4032-7. PubMed ID: 9557691
[TBL] [Abstract][Full Text] [Related]
16. T cell-tropic HIV gp120 mediates CD4 and CD8 cell chemotaxis through CXCR4 independent of CD4: implications for HIV pathogenesis.
Iyengar S; Schwartz DH; Hildreth JE
J Immunol; 1999 May; 162(10):6263-7. PubMed ID: 10229873
[TBL] [Abstract][Full Text] [Related]
17. A genetically engineered spleen necrosis virus-derived retroviral vector that displays the HIV type 1 glycoprotein 120 envelope peptide.
Jiang A; Fisher H; Pomerantz RJ; Dornburg R
Hum Gene Ther; 1999 Nov; 10(16):2627-36. PubMed ID: 10566890
[TBL] [Abstract][Full Text] [Related]
18. The HIV-1 gp120 inhibits the binding of adenosine deaminase to CD26 by a mechanism modulated by CD4 and CXCR4 expression.
Blanco J; Valenzuela A; Herrera C; Lluís C; Hovanessian AG; Franco R
FEBS Lett; 2000 Jul; 477(1-2):123-8. PubMed ID: 10899322
[TBL] [Abstract][Full Text] [Related]
19. Identification of determinants of interaction between CXCR4 and gp120 of a dual-tropic HIV-1DH12 isolate.
Lee MK; Heaton J; Cho MW
Virology; 1999 May; 257(2):290-6. PubMed ID: 10329539
[TBL] [Abstract][Full Text] [Related]
20. Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines.
Lapham CK; Ouyang J; Chandrasekhar B; Nguyen NY; Dimitrov DS; Golding H
Science; 1996 Oct; 274(5287):602-5. PubMed ID: 8849450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
